Micro-dosing with Zeifmans: Short podcasts on demystifying the business of psychedelics Zeifmans LLP

Join out host, Larry Zeifman and this week's guests, Dr. Joseph Tucker, CEO of MagicMed Industries and Kelsey Ramsden, President & CEO of MINDCURE as they discuss the rapid growth of the psychedelic industry, predict future changes within the industry and changes required for psychedelics to become mainstream.

About Zeifmans

Zeifmans is a full-service tax, accounting and consulting firm based in Toronto, Canada, ranked as one of Canada’s top 20 firms by revenue. Beyond the traditional offering, our services include business advisory, valuation, corporate finance, transaction services, corporate turnaround and insolvency, and estate and succession planning, supporting our 9,000+ clients through every step of the business life cycle. For more on our services relating directly to the cannabis and psychedelics industry, visit zeifmans.ca.

About MagicMed Industries

MagicMed Industries intends to partner with pharmaceutical and other companies to develop psychedelic-derived medicinal and licit consumer goods products.  MagicMed's molecular derivatives library, the PsybraryTM is anticipated to be an essential building block from which industry can develop new patented products.  The initial focus of the PsybraryTM is on psilocybin, which is expected to be opportunistically expanded to other psychedelics like MDMA, ketamine, Ibogaine, Mescaline, and Ayahuasca.

About MINDCURE

MINDCURE exists as a response to the current mental health crisis and urgent calls for effective treatments. MINDCURE believes in the need to reinvent the mental health care model for patients and practitioners to allow psychedelics to advance into common and accepted care. MINDCURE is focused on identifying and developing pathways and products that ease suffering, increase productivity, and enhance mental health. MINDCURE is interested in exploring diverse therapeutic areas beyond psychiatry, including digital therapeutics, neuro-supports, and psychedelics, all to improve mental health.

Join our host, Larry Zeifman and this week's guests, Henry Sant-Cassia, Founding-Partner of The Conscious Fund and Patrick Moher, CEO of Microdose Psychedelic Insights as they discuss Canadian psychedelic companies raising funds, financing for new entrants and why psychedelic companies are sought out by investors.

About Zeifmans

Zeifmans is a full-service tax, accounting and consulting firm based in Toronto, Canada, ranked as one of Canada’s top 20 firms by revenue. Beyond the traditional offering, our services include business advisory, valuation, corporate finance, transaction services, corporate turnaround and insolvency, and estate and succession planning, supporting our 9,000+ clients through every step of the business life cycle. For more on our services relating directly to the cannabis and psychedelics industry, visit zeifmans.ca.

About The Conscious Fund

The Conscious Fund invests in global early-stage ventures in psychedelic medicine, helping deliver better outcomes for mental health, addiction, and pain.

About Microdose Psychedelic Insights 

Microdose's vision is to distribute and create the most compelling content, financial analysis, engaging events, and groundbreaking education to drive the psychedelics industry into the forefront of modern medicine.

Join our host, Larry Zeifman and this week's guests, David Wood, PhD, Partner at BLG and Spencer Hawkswell, CEO of Therapsil - together they discuss CDSA exemptions, Therapsil's work within the psychedelics industry and the future of regulations for psychedelics as medication for mental health treatment.  

About Zeifmans

Zeifmans is a full-service tax, accounting and consulting firm based in Toronto, Canada, ranked as one of Canada’s top 20 firms by revenue. Beyond the traditional offering, our services include business advisory, valuation, corporate finance, transaction services, corporate turnaround and insolvency, and estate and succession planning, supporting our 9,000+ clients through every step of the business life cycle. For more on our services relating directly to the cannabis and psychedelics industry, visit zeifmans.ca.

About Borden Ladner Gervais LLP (BLG):

As the largest, truly full-service Canadian law firm, Borden Ladner Gervais LLP (BLG) delivers practical legal advice for domestic and international clients across more practices and industries than any Canadian firm. With over 725 lawyers, intellectual property agents and other professionals, BLG serves the legal needs of businesses and institutions across Canada and beyond – from M&A and capital markets, to disputes, financing, and trademark & patent registration.


About TheraPsil

TheraPsil is a non-profit coalition dedicated to helping Canadians in medical need access legal, psilocybin-assisted psychotherapy to treat end-of-life distress. TheraPsil was formed in 2019 and is made up of healthcare professionals, patients, community members, and advocates. To meet our team, click here. After over 100 days of advocating, TheraPsil facilitated precedent-setting and tangible progress in the fight for compassionate access to psilocybin therapy when it helped 4 Canadians suffering from end-of-life distress, due to a terminal illness, access approved 'section 56 exemptions' from the Minister of Health, on August 4th 2020. This was the first time section 56 exemptions for psilocybin had been approved for patients since psilocybin was made a controlled substance in 1974, in Canada. As of March 2021, TheraPsil has now supported 27 patients in 5 different provinces access legal, psilocybin-assisted psychotherapy.

Welcome back to Micro-dosing with Zeifmans - Season 2! Join our host, Larry Zeifman and this week's guests, Doug Drysdale, CEO of Cybin and Josh Bartch, Co-founder, Chairman & CEO of Mydecine Innovation Group, as they provide an industry update from where we left off at the end of season 1. 

Have questions or want to learn more? Contact us direct at info@zeifmans.ca.

About Zeifmans

Zeifmans is a full-service tax, accounting and consulting firm based in Toronto, Canada, ranked as one of Canada’s top 20 firms by revenue. Beyond the traditional offering, our services include business advisory, valuation, corporate finance, transaction services, corporate turnaround and insolvency, and estate and succession planning, supporting our 9,000+ clients through every step of the business life cycle. For more on our services relating directly to the cannabis and psychedelics industry, visit zeifmans.ca.

About Cybin

Cybin is a leading biotechnology company focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders.

About Mydecine Innovation Group

Mydecine Innovations Group™️ (NEO: MYCO) (OTC:MYCOF) (FSE:0NFA) is an emerging biotech and life sciences company dedicated to developing and commercializing innovative solutions for treating mental health problems and enhancing vitality. Mydecine has exclusive access to a full cGMP certified pharmaceutical manufacturing facility with the ability to import/export, cultivate, extract/isolate, and analyze active mushroom compounds with full government approval through Health Canada.are (non-psychedelic) medicinal mushrooms.

The mandate of this SAB continues to provide strategic guidance and direction for Mydecine’s clinical trials for PTSD, underpinned by pure data research, therapy, and scientific programs, advise on intellectual property; and, contribute commentary on Mydecine’s telehealth platform, Mindleap Health™.

Mydecine has also successfully completed multiple acquisitions since its inception.

Welcome back to season 2 of Micro-dosing with Zeifmans: short podcasts on demystifying the business of Psychedelics! Join our host Zeifmans partner, Larry Zeifman, and weekly special guests, for the next 4 weeks as we continue to explore the industry of psychedelics together.

Special guests this season include: Henri Sant – Cassia from The Conscious Fund, Dr. Joseph Tucker from MagicMed Industries, Doug Drydsale from Cybin, Spencer Hawkswell from Therapsil and Kelsey Ramsden from Mindcure.

About Zeifmans:

Zeifmans is a full-service tax, accounting and consulting firm based in Toronto, Canada, ranked as one of Canada’s top 20 firms by revenue. Beyond the traditional offering, our services include business advisory, valuation, corporate finance, transaction services, corporate turnaround and insolvency, and estate and succession planning, supporting our 9,000+ clients through every step of the business life cycle.

Since 1959, Zeifmans has been developing innovative solutions driven by creative insight. Nearly 60 years later, our diverse local team has grown to over 150 team members, while our membership with Nexia International – one of the world’s top ten accounting and consulting networks – provides access to a global team of 3,400+ partners spanning more than 120 countries. Over 4,000 of our clients are private companies – many having been with us for more than a generation; proof that our connection with our clients remains a trusted long-term relationship based on the common goal of business growth and success. To learn more about our services relating directly to the cannabis and psychedelics industry, visit zeifmans.ca.

On today's bonus episode of Micro-dosing with Zeifmans, our host Larry Zeifman reflects on key themes from our past 6 episodes, with special guests David Wood and Cameron MacDonald, both Partners at BLG and Dr. Joseph Tucker, CEO of MagicMed Industries Inc.. 

Have questions or want to learn more? Contact us direct at info@zeifmans.ca.

About Zeifmans

Zeifmans is a full-service tax, accounting and consulting firm based in Toronto, Canada, ranked as one of Canada’s top 20 firms by revenue. Beyond the traditional offering, our services include business advisory, valuation, corporate finance, transaction services, corporate turnaround and insolvency, and estate and succession planning, supporting our 9,000+ clients through every step of the business life cycle. For more on our services relating directly to the cannabis and psychedelics industry, visit zeifmans.ca.

About BLG

As Canada’s law firm, BLG provides high-value advice and advocacy to address our clients’ business challenges and problems. We go beyond legal to anticipate, consult and advise in a rapidly changing digital world.

We have extensive experience acting in specialized and complex deals and disputes. Vigilant, curious and collaborative, we harness technology and innovation to offer our clients exceptional service and value.

About MagicMed Industries Inc. 

MagicMed Industries Inc. ("MagicMed")  intends to partner with pharmaceutical and other companies to develop psychedelic-derived medicinal and licit consumer goods products. MagicMed’s molecular derivatives library, the Psybrary™ is anticipated to be an essential building block from which industry can develop new patented products. The initial focus of the Psybrary™ is on psilocybin, which is expected to be opportunistically expanded to other psychedelics like MDMA, ketamine, ibogaine, mescaline, and ayahuasca.